- Home
- FTF vs CCCC Comparison
FTF vs CCCC Comparison
Compare FTF & CCCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FTF
- CCCC
- Stock Information
- Founded
- FTF 2003
- CCCC 2015
- Country
- FTF United States
- CCCC United States
- Employees
- FTF N/A
- CCCC N/A
- Industry
- FTF Finance/Investors Services
- CCCC Biotechnology: Pharmaceutical Preparations
- Sector
- FTF Finance
- CCCC Health Care
- Exchange
- FTF Nasdaq
- CCCC Nasdaq
- Market Cap
- FTF 260.6M
- CCCC 244.9M
- IPO Year
- FTF N/A
- CCCC 2020
- Fundamental
- Price
- FTF $6.45
- CCCC $1.44
- Analyst Decision
- FTF
- CCCC Buy
- Analyst Count
- FTF 0
- CCCC 4
- Target Price
- FTF N/A
- CCCC $12.50
- AVG Volume (30 Days)
- FTF 153.9K
- CCCC 796.2K
- Earning Date
- FTF 01-01-0001
- CCCC 05-07-2025
- Dividend Yield
- FTF 11.45%
- CCCC N/A
- EPS Growth
- FTF N/A
- CCCC N/A
- EPS
- FTF N/A
- CCCC N/A
- Revenue
- FTF N/A
- CCCC $35,584,000.00
- Revenue This Year
- FTF N/A
- CCCC N/A
- Revenue Next Year
- FTF N/A
- CCCC $36.32
- P/E Ratio
- FTF N/A
- CCCC N/A
- Revenue Growth
- FTF N/A
- CCCC 71.44
- 52 Week Low
- FTF $5.76
- CCCC $1.43
- 52 Week High
- FTF $6.56
- CCCC $8.08
- Technical
- Relative Strength Index (RSI)
- FTF 41.22
- CCCC 20.65
- Support Level
- FTF $6.41
- CCCC $1.79
- Resistance Level
- FTF $6.48
- CCCC $2.28
- Average True Range (ATR)
- FTF 0.05
- CCCC 0.15
- MACD
- FTF 0.00
- CCCC -0.02
- Stochastic Oscillator
- FTF 28.57
- CCCC 0.59
About FTF Franklin Limited Duration Income Trust of Beneficial Interest
Franklin Limited Duration Income Trust is a closed-end investment company based in the United States. It conducts its investment to provide high, current income, with a secondary objective of capital appreciation. To align with its investment objective is to invest in a diversified mix of fixed-income securities. Its portfolio is dominated by considerable investments in high-yield corporate bonds while touching upon other avenues such as senior secured floating rate corporate loans, mortgage-backed securities, commercial mortgage-backed securities, asset-backed securities, common stocks, and other short-term investments.
About CCCC C4 Therapeutics Inc.
C4 Therapeutics Inc is a biopharmaceutical company advancing targeted protein degradation science to develop a new generation of small-molecular medicines to transform how the disease is treated. Its TORPEDO platform enables the discovery of a new class of targeted investigational small-molecule medicines called protein degraders.